“How Do We Practically Do This?” Expert Guidance and Interactive Practice on SGLT2i Integration Across the Spectrum of Heart Failure

Deepen your understanding of the role SGLT2 inhibitors play in treating heart failure through exploration of real-world evidence and gain expert-informed strategies in counseling and shared decision-making to personalize patient care, via an on-demand webcast with accompanying slides, downloadable clinical resource, and ClinicalThought commentary.

Share

Program Content

Activities

SGLT2i and Heart Failure
SGLT2 Inhibitor Use in People With Heart Failure
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 23, 2024

Expires: August 22, 2025

Faculty

cover img faculity

Javed Butler, MD, MPH, MBA

Maxwell A. and Gayle H. Clampitt Endowed Chair
President and Chief Research Executive
Baylor Scott and White Research Institute
Dallas, Texas
Senior Vice President, Baylor Scott & White Health
Distinguished Professor of Medicine
University of Mississippi
Jackson, Mississippi

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.

Boehringer Ingelheim Pharmaceuticals, Inc.

Eli Lilly and Company